Veeda Clinical Research Limited - Draft Red Herring Prospectus
Clinical Research Organation (CRO) Market Report
Articles of Association
Memorandum of Association
Certificate of Incorporation
List of Material Creditors
Resolution of the BOD approving the Offer
Resolution of our Shareholders approving the Offer
Resolution of the BOD amending the Offer
Resolution of our Shareholders amending the Offer
Resolution of the IPO Committee approving and adopting the DRHP
Resolution of the BOD approving the working capital requirements
Joint Venture Agreement with Somru Bioscience Inc.
Share sale and purchase agreement between Company, Bioneeds, Promoters of Bioneeds and Canbank Venture
Investment Agreement and Addendum Agreement between Company, Bioneeds, and Promoters of Bioneeds
Share Purchase Agreement dated September 27, 2018 between Promoter, CX AIF, Company, Founder Shareholders, and Founder Directors
Share purchase agreement between Vistra ITCL (India) Limited and Vatsal Sanjay Saraf in November 2021
In-principle listing approvals of BSE and NSE
In-principle listing approvals of NSE
Tripartite Agreement between Company, NSDL, RTA
Dividend Policy
UPSI Policy
Offer Agreement
Registrar Agreement
SEBI final observation letter
Share subscription agreements between Company and HNIs in December 2021
Secondary Sale Share Purchase Documents
Share purchase agreements between CX AIF and HNIs in November 2021 & 22. Consent letter of Directors and Intermediaries to offer
Consent letter of Directors and Intermediaries to offer
Copies of annual reports for the 2018-19
Copies of annual reports for the 2019-20
Copies of annual reports for the 2020-21
Due diligence certificate to SEBI from the BRLMs, dated September 27, 2021
Fee letter as amended on February 8, 2022
Fresh certificate of incorporation dated June 30, 2021
Fresh certificate of incorporation dated November 22, 2005
Report titled “Clinical Research Organization (CRO) Market Report dated January 2022”
Resolution of the Board of Directors of our Company, dated May 22, 2021, approving the Offer
SEBI final observation letter number SEBIHOCFDDIL2RGNKMOWP384412021
Share Subscription Agreement dated May 29, 2021 executed between our Company and Sabre Partners
